Search
Wednesday 14 October 2015
  • :
  • :

(UMPQ) (TRV) (ACHN) (MMC) Active News Update: Umpqua Holdings (NASDAQ:UMPQ), Travelers Companies (NYSE:TRV), Achillion Pharmaceuticals,. (NASDAQ:ACHN), Marsh & McLennan Companies, (NYSE:MMC)

On Friday, Umpqua Holdings Corp (NASDAQ:UMPQ)’s shares declined -1.59% to $16.05.

Umpqua Holdings Corporation (UMPQ), parent company of Umpqua Bank and Umpqua Investments, declared that it will host its third quarter 2015 earnings conference call on Thursday, October 22, 2015, at 10:00 a.m. PST (1:00 p.m. EST). During the call, the Company will provide an update on recent activities and talk about its third quarter 2015 financial results, which are predictable to be released after the market closes on October 21, 2015. There will be a live question-and-answer session following the presentation.

Umpqua Holdings Corporation, through its auxiliaries, engages in the commercial and retail banking, and retail brokerage businesses. It operates through two segments, Community Banking and Home Lending. The Community Banking segment provides loan and deposit products to business and retail customers. The Home Lending segment originates, sells, and services residential mortgage loans. I

Travelers Companies Inc (NYSE:TRV)’s shares gained 1.72% to $100.03.

The Travelers Companies, Inc. (TRV) declared the results of its third annual Consumer Risk Index, which revealed a significantly higher number of people are worried about cyber threats. Cyber-related concerns grew by more than 20 percentage points from last year, moving from the fifth-ranked to the third-ranked concern overall. The survey found that one in four Americans say they have been the victim of a data breach or cyber attack.

Other results from the survey indicate that a majority of Americans (57 percent) continue to believe the world is becoming riskier. Women, more than men, see the world becoming riskier, as do people over the age of 40. Financial security is the top concern for the third successive year, and many Americans remain worried about distracted driving and severe weather.

Cyber Concerns

Of the cyber risks that were listed as potential concerns, respondents worried the most about their bank accounts being hacked. Americans under the age of 55 are generally more likely to worry a great deal about cyber risks than those over 55.

The Travelers Companies, Inc., through its auxiliaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the Unites states and internationally. It operates in three segments: Business and International Insurance; Bond & Specialty Insurance; and Personal Insurance.

At the end of Friday’s trade, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)‘s shares surged 6.95% to $7.21.

Achillion Pharmaceuticals, Inc. (ACHN) declared additional interim results from a Phase 2 study evaluating odalasvir (also known as ACH-3102), a NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for either six or eight weeks of treatment in patients with treatment-naïve genotype 1 chronic hepatitis C virus (HCV) infection. Of the patients treated for six weeks in this cross-over cohort, 100 percent (n=6/6) remained HCV RNA undetectable twelve weeks after concluding therapy (SVR12). Formerly, Achillion stated results from this study counting 100 percent SVR24 for the initial cohorts counting 12 patients treated for eight weeks and 100 percent SVR24 for 12 patients treated for six weeks.

In May 2015, Achillion declared it had granted Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, an exclusive, worldwide license to develop and, upon regulatory approval, commercialize HCV products and regimens containing one or more of Achillion’s HCV assets which comprise odalasvir, ACH-3422, and sovaprevir.

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.

Marsh & McLennan Companies, Inc. (NYSE:MMC), ended its Friday’s trading session with 0.96% gain, and closed at $52.58.

Marsh & McLennan Companies, Inc. (MMC), a global professional services firm offering clients advice and solutions in risk, strategy and people, plans to declare third quarter 2015 results on Tuesday, October 27, 2015, in a news release to be issued before the market opens. The release will also be accessible on the Marsh & McLennan Companies website at www.mmc.com.

President and CEO Dan Glaser and CFO Mike Bischoff will lead a talk about with investors regarding financial results at 8:30 a.m. Eastern time on October 27. The talk about will comprise a question-and-answer period.

Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions primarily in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services; and Consulting.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *